Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RNA

Atrium Therapeutics Inc

Jun 18 • 04:00PM ET

12.66

+0.18 1.44 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: KPTI OABI CAMP CNTX HUMA TENX TNXP UNCY WHWK MIST

| Held by: VTI IWM VB VXF IWO JSML SCHA VTWO VBR VBK

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	0.22%	Shs Outstand	17.11M	Perf Week	1.85%
Market Cap	216.56M	Forward P/E	-	EPS next Y	-5.61	Insider Trans	-60.82%	Shs Float	17.07M	Perf Month	-2.24%
Enterprise Value	-48.61M	PEG	-	EPS next Q	-1.16	Inst Own	86.52%	Short Float	21.40%	Perf Quarter	-0.24%
Income	-	P/S	-	EPS this Y	-4.84%	Inst Trans	13.95%	Short Ratio	9.92	Perf Half Y	-
Sales	-	P/B	0.93	EPS next Y	-19.45%	ROA	-	Short Interest	3.65M	Perf YTD	-14.17%
Book/sh	13.69	P/C	0.81	EPS next 5Y	-10.69%	ROE	-	52W High	16.77 -24.51%	Perf Year	-
Cash/sh	15.66	P/FCF	-	EPS past 3/5Y	-178.43% -	ROIC	-	52W Low	11.40 11.02%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	38.09% -	Gross Margin	-	Volatility	3.95% 4.21%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.54	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.04	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.73	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	13.04	EPS Q/Q	-	SMA20	1.27%	Beta	-	Target Price	36.75
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-2.61%	Rel Volume	0.80	Prev Close	12.48
Employees	-	LT Debt/Eq	0.00	Earnings	May 14 AMC	SMA200	-5.17%	Avg Volume	368.26K	Price	12.66
IPO	Jun 12, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	7.62% 881.75%	Trades		Volume	294,113	Change	1.44%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)